Grünenthal has entered a new partnership with DKSH to expand access to four established pain medicines across Asia-Pacific.

Johnson & Johnson has reported new long-term data showing that half of patients in early line relapsed or refractory multiple myeloma remained alive and progression-free for at least five years after ...

Roche has welcomed MHRA marketing authorisation for Gazyvaro, indicated for adults with moderate to severe, active, autoantibody-positive systemic lupus erythematosus receiving standard therapy. The ...

EpilepsyGTx and Viralgen have announced a partnership to advance production of EPY201, EpilepsyGTx’s lead investigational ...

Sanofi and Cheplapharm have announced plans to establish a new strategic partnership that will see Cheplapharm take over 20 mature medicines and three manufacturing sites worldwide. The agreement will ...

Axoltis Pharma has reported topline findings from SEALS, its phase 2 study of NX210c in Amyotrophic Lateral Sclerosis. The company said the drug candidate, which aims to restore the blood brain ...

GSK has announced that Japan’s Ministry of Health, Labour and Welfare has approved a prefilled syringe presentation of ...

Grünenthal has agreed to acquire Stivarga, an oral treatment for advanced cancers, from Bayer AG for up to €375 million. The company said the deal aligns with its strategy to purchase established ...

The CHMP opinion is based on the phase 3 MajesTEC-9 study, which showed a 71% reduction in risk of progression or death and a 40% reduction in risk of death versus standard of care. Nearly two-thirds ...

HepaRegeniX has announced that the first patient undergoing major liver resection due to liver metastases from colorectal cancer has completed 28 days of treatment with darizmetinib in the second ...

Ethiopia, Norway and the UK have pledged US$240 million to support CEPI’s five‑year plan to strengthen global readiness for epidemic and pandemic threats. Ethiopia will contin ...

Zerion Pharma has announced that one of its partners has submitted a marketing authorisation application in several European countries for a medicinal product formulated with the company’s Dispersome ...